|
Report Date : |
09.07.2014 |
IDENTIFICATION DETAILS
|
Name : |
CARL ZEISS MEDITEC AG |
|
|
|
|
Registered Office : |
Göschwitzer
Str. 51-52, D 07745 |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
30.09.2013 |
|
|
|
|
Date of Incorporation : |
04.10.1995 |
|
|
|
|
Legal Form : |
Public limited company |
|
|
|
|
Line of Business : |
·
Manufacturer
of technical instruments and supplies for medical purposes n.e.c. ·
Wholesale
of medical and orthopedic goods, dental and laboratory supplies ·
Other
service activities n. e. c. |
|
|
|
|
No of Employees : |
1,112 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2014
|
Country Name |
Previous Rating (31.12.2013) |
Current Rating (31.03.2014) |
|
Germany |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderate Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderate High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
GERMANY ECONOMIC OVERVIEW
The German economy - the fifth largest economy in the world in PPP terms and Europe's largest - is a leading exporter of machinery, vehicles, chemicals, and household equipment and benefits from a highly skilled labor force. Like its Western European neighbors, Germany faces significant demographic challenges to sustained long-term growth. Low fertility rates and declining net immigration are increasing pressure on the country's social welfare system and necessitate structural reforms. Reforms launched by the government of Chancellor Gerhard SCHROEDER (1998-2005), deemed necessary to address chronically high unemployment and low average growth, has contributed to strong growth and falling unemployment. These advances, as well as a government subsidized, reduced working hour scheme, help explain the relatively modest increase in unemployment during the 2008-09 recession - the deepest since World War II - and its decrease to 5.3% in 2013. The new German government introduced a minimum wage of $11 per hour to take effect in 2015. Stimulus and stabilization efforts initiated in 2008 and 2009 and tax cuts introduced in Chancellor Angela MERKEL's second term increased Germany's total budget deficit - including federal, state, and municipal - to 4.1% in 2010, but slower spending and higher tax revenues reduced the deficit to 0.8% in 2011 and in 2012 Germany reached a budget surplus of 0.1%. A constitutional amendment approved in 2009 limits the federal government to structural deficits of no more than 0.35% of GDP per annum as of 2016 though the target was already reached in 2012. Following the March 2011 Fukushima nuclear disaster, Chancellor Angela MERKEL announced in May 2011 that eight of the country's 17 nuclear reactors would be shut down immediately and the remaining plants would close by 2022. Germany hopes to replace nuclear power with renewable energy. Before the shutdown of the eight reactors, Germany relied on nuclear power for 23% of its electricity generating capacity and 46% of its base-load electricity production
|
Source
: CIA |
Göschwitzer
Str. 51-52
D 07745
Jena
Telephone:03641/220-0
Telefax: 03641/220-012
Homepage:
www.meditec.zeiss.de
E-mail: info@meditec.zeiss.com
Active
DE811922737
Business relations are permissible.
LEGAL FORM Public
limited company
Date of foundation: 04.10.1995
Registered on: 30.11.1995
Commercial Register: Local court 07745 Jena
under: HRB
205623
Share capital: EUR 81,309,610.00
The
company is listed on the stock market.
Shareholder:
Carl Zeiss AG
Carl-Zeiss-Str. 22
D 73447 Oberkochen
Legal form: Public
limited company
Share capital: EUR
120,000,000.00
Share: 65.050 %
Registered on: 22.03.2004
Reg. data: 89073 Ulm, HRB
501555
Shareholder:
Massachusetts Mutual Life
Insurance Company
USA - Massachusetts
Legal form: Other legal
form
Share: 2.980 %
President of the Board of Directors:
Dr. Ludwig Monz
Pfarrer-Brantzen-Str. 48
D 55122 Mainz
born: 20.10.1963
Member of the Board of Directors:
Thomas Simmerer
D 23628 Krummesse
born: 19.10.1962
Member of the Board of Directors:
Dr. Christian Müller
Lise-Meitner-Weg 2
D 89129 Langenau
born: 03.08.1967
President of the Supervisory Board:
Dr. Michael Kaschke
Wiesenweg 20
D 73447 Oberkochen
born: 18.06.1957
Profession: Physicist
Vice-president of the Supervisory Board:
Dr. Markus Guthoff
D 47798 Krefeld
born: 12.05.1964
Member of the Supervisory Board:
Dr. Wolfgang Reim
D 19217 Campow
born: 12.11.1956
Profession: Businessman
Marital status: married
Member of the Supervisory Board:
Thomas Spitzenpfeil
Schirnerstr. 24
D 41515 Grevenbroich
born: 22.12.1962
Profession: Businessman
Marital status: married
Member of the Supervisory Board:
Cornelia Grandy
D 73447 Oberkochen
Marital status: unknown
Member of the Supervisory Board:
Jörg Heinrich
D 07745 Jena
Marital status: unknown
Proxy:
Jörg Roeper
Richard-Strauss-Weg 8
D 07743 Jena
authorized to jointly
represent the company
born: 15.03.1962
Proxy:
Falk Hartwig
Argelsrieder Str. 19a
D 81475 München
authorized to jointly
represent the company
born: 25.05.1964
Proxy:
Dr. Ralf Kuschnereit
828 Cascade DR
USA - Sunnyvale
authorized to jointly represent
the company
born: 08.10.1968
Proxy:
Jan Willem de Cler
NL Rotterdam
authorized to jointly
represent the company
born: 05.01.1965
Nationality: Dutch
Proxy:
Dirk Brunner
USA San Francisco, CA
authorized to jointly
represent the company
born: 10.07.1970
Nationality: USA
Proxy:
Dr. Till Sellschopp
D 99423 Weimar
authorized to jointly
represent the company
born: 25.07.1976
Further functions/participations of Dr.
Christian Müller (Member of the Board of Directors)
Manager:
Carl Zeiss Meditec Asset
Management
Verwaltungsgesellschaft
mbH
Göschwitzer Str. 51-52
D 07745 Jena
Legal form: Private
limited company
Share capital: EUR 25,000.00
Registered
on: 16.05.2000
Reg. data: 07745 Jena, HRB 208261
04.10.1995 - 11.11.1999 AESCULAP
- MEDITEC GMBH
Prüssingstr. 41
D 07745 Jena
Private
limited company
11.11.1999 - 22.02.2002 ASCLEPION-MEDITEC
AG
Prüssingstr. 41
D 07745 Jena
Public limited company
23.02.2002 - 04.07.2002 ASCLEPION-MEDITEC
AG
Göschwitzer Str. 51-52
D 07745 Jena
Public limited company
18.01.2008 - 17.10.2011 Member
of the Board of Directors
Dr. Ludwig Monz
D
55122 Mainz
Sectors
32501 Manufacturer of technical instruments and
supplies for medical purposes n.e.c.
46462 Wholesale of medical and orthopedic goods,
dental and laboratory supplies
96090 Other service activities n. e. c.
Works:
Carl Zeiss Meditec AG
Carl-Zeiss-Promenade 10
D 07745 Jena
TEL.: 03641/643929
Works:
Carl Zeiss Meditec AG
Kistlerhofstr. 75
D 81379 München
Branch:
Carl Zeiss Meditec AG
Rudolf-Eber-Str. 11
D 73447 Oberkochen
TEL.: 07364/200
Shareholder:
Carl Zeiss Meditec Asset
Management
Verwaltungsgesellschaft
mbH
Göschwitzer Str. 51-52
D 07745 Jena
Legal form: Private limited company
Company Status: active
Share capital: EUR 25,000.00
Share: EUR 25,000.00
Reg. data: 16.05.2000
Local court
07745 Jena
HRB 208261
Shareholder:
S & V Technologies
GmbH
Neuendorfstr. 20a
D 16761 Hennigsdorf
Legal form: Private
limited company
Company Status: active
Share capital: EUR 100,000.00
Share: EUR 2,000.00
Reg. data: 26.11.2013
Local court
16816 Neuruppin
HRB 10630 NP
Payment experience: within agreed terms
Negative information: We have no negative information at hand.
The maximum credit is our recommendation for
the maximum credit limit for the inquired
company.
Balance
sheet year: 2012/2013
Type of ownership: proprietor
Share: 100.00 %
Address Paintweg
10
D 92685 Floß
Type of ownership: Tenant
Address Göschwitzer
Str. 51-52
D 07745 Jena
Land register documents were not available.
Principal bank
DEUTSCHE BANK, 07703 JENA
Sort. code: 82070000
BIC: DEUTDE8EXXX
Further banks
COMMERZBANK VORMALS DRESDNER BANK, 07708 JENA
Sort. code: 82080000
BIC: DRESDEFF827
UNICREDIT BANK - HYPOVEREINSBANK, 07704 JENA
Sort. code: 83020087
BIC: HYVEDEMM463
Turnover: 2011/2012 EUR 519,683,000.00
2012/2013 EUR 566,978,000.00
Profit: 2011/2012 EUR 47,083,000.00
2012/2013 EUR 51,017,000.00
further business figures:
Equipment: EUR 10,879,000.00
Ac/ts receivable: EUR 277,843,000.00
Liabilities: EUR 55,171,000.00
Employees:
1,112
- Trainees:
8
Balance sheet ratios 01.10.2012 - 30.09.2013
Equity ratio [%]: 85.33
Liquidity ratio: 5.52
Return on total capital [%]: 6.10
Balance sheet ratios 01.10.2011 - 30.09.2012
Equity ratio [%]: 83.12
Liquidity ratio: 10.00
Return on total capital [%]: 5.71
Balance sheet ratios 01.10.2010 - 30.09.2011
Equity ratio [%]: 84.00
Liquidity ratio: 10.00
Return on total capital [%]: 4.67
Balance sheet ratios 01.10.2009 - 30.09.2010
Equity ratio [%]: 95.40
Liquidity ratio: 10.00
Return on total capital [%]: 3.51
The equity
ratio indicates the portion of the equity as compared to the total capital. The
higher the equity ratio, the better the economic stability (solvency) and thus
the financial autonomy of a company.
The
liquidity ratio shows the proportion between adjusted receivables and net
liabilities. The higher the ratio, the lower the company's financial dependancy
from external creditors.
The return
on total capital shows the efficiency and return on the total capital employed
in the company. The higher the return on total capital, the more economically
does the company work with the invested capital.
Type of balance sheet: Company
balance sheet
Financial year: 01.10.2012
- 30.09.2013
ASSETS EUR 943,884,000.00
Fixed assets EUR 572,160,000.00
Intangible assets EUR 180,036,000.00
Concessions, licences,
rights EUR 92,026,000.00
Goodwill EUR 88,010,000.00
Tangible assets EUR 19,983,000.00
Land / similar
rights EUR 3,227,000.00
Plant / machinery EUR 4,618,000.00
Other tangible assets /
fixtures and
fittings EUR 10,879,000.00
Advance payments made /
construction
in progress EUR 1,259,000.00
Financial assets EUR 372,141,000.00
Shares in participations
/
subsidiaries and the
like EUR 239,372,000.00
Shares in related
companies EUR 239,370,000.00
Shares in investee
companies EUR 2,000.00
Loans to participations
/
subsidiaries and the
like EUR 131,930,000.00
Loans to related
companies EUR 131,930,000.00
Other loans EUR 839,000.00
Current assets EUR 363,240,000.00
Stocks EUR 85,394,000.00
Raw materials,
consumables and
supplies EUR 42,071,000.00
Finished goods / work in
progress EUR 44,288,000.00
Advance payments
made EUR 216,000.00
Minus received advance
payments for
orders / installments
for stocks EUR -1,181,000.00
Accounts receivable EUR 277,843,000.00
Trade debtors EUR 20,993,000.00
Amounts due from related
companies EUR 255,907,000.00
Amounts due from
investee companies EUR 14,000.00
Other debtors and
assets EUR 929,000.00
Liquid means EUR 3,000.00
Remaining other
assets EUR 8,484,000.00
Accruals (assets) EUR 990,000.00
Active difference from
asset
offsetting EUR 7,494,000.00
LIABILITIES EUR 943,884,000.00
Shareholders' equity EUR 813,046,000.00
Capital EUR 81,310,000.00
Subscribed capital
(share capital) EUR 81,310,000.00
Reserves EUR 649,394,000.00
Capital reserves EUR 646,454,000.00
Retained earnings /
revenue reserves EUR
2,940,000.00
Balance sheet profit/loss
(+/-) EUR 82,342,000.00
Balance sheet profit /
loss EUR 82,342,000.00
Items between
shareholders' equity and
debt capital EUR 333,000.00
Allowances / bonuses EUR 333,000.00
Provisions EUR 55,223,000.00
Provisions for taxes EUR 6,736,000.00
Other / unspecified
provisions EUR 48,487,000.00
Liabilities EUR 55,171,000.00
Other liabilities EUR 55,171,000.00
Trade creditors (for IAS
incl. bills
of exchange) EUR 25,829,000.00
Liabililties due to related
companiesEUR 25,803,000.00
Liabilities due to
investee companiesEUR
189,000.00
Unspecified other
liabilities EUR 3,350,000.00
Other liabilities EUR 20,111,000.00
Deferrals
(liabilities) EUR 1,146,000.00
Deferred taxes (not
included under
provisions/liabilities)
EUR 18,965,000.00
Guarantees and other
commitments EUR 6,924,000.00
Guarantees /
warranties EUR 6,924,000.00
Guarantees EUR 6,924,000.00
PROFIT AND LOSS ACCOUNT (cost of sales method)
according to Comm.
Code (HGB)
Sales EUR 566,978,000.00
Manufacturing costs EUR 321,750,000.00
Gross result on sales EUR 245,228,000.00
Distribution costs EUR 91,105,000.00
General administration
expenses EUR 34,701,000.00
Research and development
costs EUR 67,804,000.00
Other operating
income EUR 46,181,000.00
Other operating
expenses EUR 12,969,000.00
Operating result from
continuing
operations EUR 84,830,000.00
Interest result (+/-) EUR -4,550,000.00
Interest and similar
income EUR 1,334,000.00
Interest and similar
expenses EUR 5,884,000.00
Other financial
result EUR 2,808,000.00
Income from securities
and loans from
financial assets EUR 2,808,000.00
Financial result
(+/-) EUR -1,742,000.00
Result from ordinary
operations (+/-) EUR 83,088,000.00
Extraordinary
expenses EUR 748,000.00
Extraordinary result
(+/-) EUR -748,000.00
Income tax / refund of
income tax (+/-)EUR -31,323,000.00
Tax (+/-) EUR -31,323,000.00
Annual surplus / annual
deficit EUR 51,017,000.00
Type of balance sheet: Company
balance sheet
Financial year: 01.10.2011
- 30.09.2012
ASSETS EUR 938,498,000.00
Fixed assets EUR 580,514,000.00
Intangible assets EUR 196,858,000.00
Concessions, licences,
rights EUR 101,514,000.00
Goodwill EUR 95,344,000.00
Tangible assets EUR 16,315,000.00
Land / similar
rights EUR 3,390,000.00
Plant / machinery EUR 4,797,000.00
Other tangible assets /
fixtures and
fittings EUR 7,192,000.00
Advance payments made /
construction
in progress EUR 936,000.00
Financial assets EUR 367,341,000.00
Shares in participations
/
subsidiaries and the
like EUR 233,372,000.00
Shares in related
companies EUR 233,370,000.00
Shares in investee
companies EUR 2,000.00
Loans to participations
/
subsidiaries and the
like EUR 133,969,000.00
Loans to related
companies EUR 133,969,000.00
Current assets EUR 346,693,000.00
Stocks EUR 82,895,000.00
Raw materials,
consumables and
supplies EUR 36,048,000.00
Finished goods / work in
progress EUR 47,940,000.00
Advance payments
made EUR 216,000.00
Minus received advance
payments for
orders / installments
for stocks EUR -1,309,000.00
Accounts receivable EUR 143,774,000.00
Trade debtors EUR 20,088,000.00
Amounts due from related
companies EUR 120,399,000.00
Other debtors and
assets EUR 3,287,000.00
Liquid means EUR 120,024,000.00
Remaining other assets EUR 11,291,000.00
Accruals (assets) EUR 834,000.00
thereof disagio EUR 18,000.00
Active difference from
asset
offsetting EUR 10,457,000.00
LIABILITIES EUR 938,498,000.00
Shareholders' equity EUR 794,553,000.00
Capital EUR 81,310,000.00
Subscribed capital
(share capital) EUR 81,310,000.00
Reserves EUR 649,394,000.00
Capital reserves EUR 646,454,000.00
Retained earnings /
revenue reserves EUR
2,940,000.00
Balance sheet profit/loss
(+/-) EUR 63,849,000.00
Balance sheet profit /
loss EUR 63,849,000.00
Items between
shareholders' equity and
debt capital EUR 113,000.00
Allowances / bonuses EUR 113,000.00
Provisions EUR 67,693,000.00
Provisions for taxes EUR 8,188,000.00
Other / unspecified
provisions EUR 59,505,000.00
Liabilities EUR 52,044,000.00
Other liabilities EUR 52,044,000.00
Trade creditors (for IAS
incl. bills
of exchange) EUR 24,790,000.00
Liabililties due to
related companiesEUR
18,461,000.00
Liabilities due to
investee companiesEUR
206,000.00
Unspecified other
liabilities EUR 8,587,000.00
Other liabilities EUR 24,095,000.00
Deferrals
(liabilities) EUR 956,000.00
Deferred taxes (not
included under
provisions/liabilities)
EUR 23,139,000.00
PROFIT AND LOSS ACCOUNT (cost of sales method)
according to Comm.
Code (HGB)
Sales EUR 519,683,000.00
Manufacturing costs
EUR 287,303,000.00
Gross result on sales
EUR 232,380,000.00
Distribution costs
EUR 86,471,000.00
General administration expenses
EUR 34,566,000.00
Research and development costs
EUR 63,736,000.00
Other operating income
EUR 27,553,000.00
Other operating expenses
EUR 15,662,000.00
Operating result from continuing
operations
EUR 59,498,000.00
Interest result (+/-)
EUR 1,085,000.00
Interest and similar income
EUR 2,211,000.00
Interest and similar expenses
EUR 1,126,000.00
Other financial result
EUR 5,894,000.00
Income from securities and loans from
financial assets
EUR 5,894,000.00
Financial result (+/-)
EUR 6,979,000.00
Result from ordinary operations (+/-)
EUR 66,477,000.00
Extraordinary expenses
EUR 748,000.00
Extraordinary result (+/-)
EUR -748,000.00
Income tax / refund of income tax (+/-)EUR -18,646,000.00
Tax (+/-)
EUR -18,646,000.00
Annual surplus / annual deficit
EUR 47,083,000.00
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 59.79 |
|
|
1 |
Rs. 102.42 |
|
Euro |
1 |
Rs. 81.32 |
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
DPT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall
operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.